Published in Cancer Weekly, December 18th, 1995
According to the poster presentation, responses were assessed by modified AIDS Clinical Trial Group (ACTG) criteria. A total of 258 patients were enrolled in the trial; of these, 239 patients (131 Doxil and 108 ABV) received more than two cycles of therapy...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.